Business Wire- ALung Technologies, Inc., the leading provider of low-flow extracorporeal carbon dioxide removal (ECCO2R) technologies for treating patients with acute respiratory failure, announced today the closing of a $36 million Series C financing, including existing convertible notes.
Recent Posts

A Year in Review: A comprehensive look at UPMC Enterprises 2020
Over the last year, UPMC Enterprises, our portfolio companies, and select partners have all supported UPMC’s mission of Life Changing Medicine. In the booklet below, we have compiled highlights from a truly unique year and recognize the team members and projects that have enabled our success.
Read More →

Infectious Disease Connect Earns Top Marks from Customers in KLAS Research
UPMC Enterprises portfolio company, ID Connect, recently received top scores from KLAS Research, reflecting the quality of its services and high customer satisfaction.
Read More →

Meet the Pets of UPMC Enterprises
When wet noses and furry tails started popping up on videoconferences, we had to ask: How many of our colleagues have brought home a pet during the pandemic?
Read More →